Alesse is an oral contraceptive pill containing estrogen and progestin components. It is taken to prevent pregnancy by providing hormonal signals that mimic natural menstrual cycle phases. The estrogen moiety prevents ovulation by inhibiting the hypothalamic-pituitary axis releasing gonadotropins. The progestin component thickens cervical mucus to impede sperm penetration and alters the endometrial lining to reduce implantation potential. Together these hormonal signals suppress follicular development and maintain a stable luteal environment within the body. This combined action results in a reversible suppression of fertility without affecting normal hormonal regulation elsewhere.

Alesse is a combined oral contraceptive pill that prevents pregnancy. It contains ethinyl estradiol and levonorgestrel which work together to suppress ovulation. The estrogen component inhibits the release of hormones that trigger egg maturation. The progestin component thickens cervical mucus and alters the uterine lining to block sperm entry and implantation. These combined actions create a hormonal environment that reliably prevents fertilization. The pill also provides predictable menstrual cycle regulation for users.

Some users experience nausea, especially when first starting the pill. Headaches and dizziness are also reported frequently. Tenderness in the breasts can occur as a hormonal response. Spotting or irregular bleeding may happen between periods. Mood fluctuations such as irritability or mild depression are noted by some. Skin changes like acne or increased oiliness are common among users. Weight gain or fluid retention can be observed, though varies widely. Fatigue or changes in libido are occasionally described in clinical reports.

Common side effects of Alesse may include nausea headache breast tenderness spotting and mild bloating. Some users report changes in menstrual flow or timing that are usually short lived. Rarely more serious symptoms such as severe abdominal pain or signs of blood clot formation can appear but they occur infrequently. These reactions do not necessarily indicate a health problem and often resolve without intervention. Most of the reported effects are mild and tend to diminish with continued use. Long term safety data show no significant increase in serious adverse events in typical user populations.